CR20160146A - Derivados de urea indol sustituido con glucopiranosil y su uso como inhibidores sglt - Google Patents

Derivados de urea indol sustituido con glucopiranosil y su uso como inhibidores sglt

Info

Publication number
CR20160146A
CR20160146A CR20160146A CR20160146A CR20160146A CR 20160146 A CR20160146 A CR 20160146A CR 20160146 A CR20160146 A CR 20160146A CR 20160146 A CR20160146 A CR 20160146A CR 20160146 A CR20160146 A CR 20160146A
Authority
CR
Costa Rica
Prior art keywords
glucopiranosil
indol
urea
derivatives
replaced
Prior art date
Application number
CR20160146A
Other languages
English (en)
Inventor
Todd Fields
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CR20160146A publication Critical patent/CR20160146A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044Pyrrole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a un compuesto de Fórmula I: o una sal del mismo farmacéuticamente aceptable.
CR20160146A 2013-11-01 2016-03-31 Derivados de urea indol sustituido con glucopiranosil y su uso como inhibidores sglt CR20160146A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361898494P 2013-11-01 2013-11-01
PCT/US2014/062548 WO2015065956A1 (en) 2013-11-01 2014-10-28 Glucopyranosyl-substituted indole-urea derivatives and their use as sglt inhibitors

Publications (1)

Publication Number Publication Date
CR20160146A true CR20160146A (es) 2016-05-30

Family

ID=51862614

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20160146A CR20160146A (es) 2013-11-01 2016-03-31 Derivados de urea indol sustituido con glucopiranosil y su uso como inhibidores sglt

Country Status (39)

Country Link
US (1) US9145437B2 (es)
EP (1) EP3063162B1 (es)
JP (1) JP6147429B2 (es)
KR (1) KR101838826B1 (es)
CN (1) CN105636972B (es)
AP (1) AP2016009137A0 (es)
AR (1) AR098134A1 (es)
AU (1) AU2014342612B2 (es)
BR (1) BR112016008704B1 (es)
CA (1) CA2924516C (es)
CL (1) CL2016000988A1 (es)
CR (1) CR20160146A (es)
CY (1) CY1119540T1 (es)
DK (1) DK3063162T3 (es)
DO (1) DOP2016000062A (es)
EA (1) EA029516B1 (es)
ES (1) ES2646125T3 (es)
HK (1) HK1222661A1 (es)
HR (1) HRP20171514T1 (es)
HU (1) HUE034689T2 (es)
IL (1) IL244896B (es)
JO (1) JO3298B1 (es)
LT (1) LT3063162T (es)
MA (1) MA38991B1 (es)
ME (1) ME02839B (es)
MX (1) MX2016005428A (es)
NO (1) NO3099623T3 (es)
NZ (1) NZ717880A (es)
PE (1) PE20160663A1 (es)
PH (1) PH12016500809A1 (es)
PL (1) PL3063162T3 (es)
PT (1) PT3063162T (es)
RS (1) RS56417B1 (es)
SG (1) SG11201602950UA (es)
SI (1) SI3063162T1 (es)
TN (1) TN2016000125A1 (es)
TW (1) TWI657093B (es)
UA (1) UA117137C2 (es)
WO (1) WO2015065956A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110128493B (zh) * 2018-02-08 2021-01-12 亚宝药业集团股份有限公司 吡喃糖取代杂环化合物的盐及其制备方法和用途
WO2024055932A1 (zh) * 2022-09-13 2024-03-21 亚宝药业集团股份有限公司 氮杂环化合物、其药物组合物和用于预防和/或治疗疾病的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200501094B (en) * 2002-08-08 2006-10-25 Kissei Pharmaceutical Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
ZA200501549B (en) * 2002-08-23 2006-07-26 Kissei Pharmaceutical Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof and intermediate for the production thereof
US20080139484A1 (en) * 2004-09-29 2008-06-12 Kissei Pharmaceutical Co., Ltd. 1(Beta-D-Glycopyranosyl)-3-Substituted Nitrogenous Heterocyclic Compound, Medicinal Composition Containing the Same, and Medicinal Use Thereof
US7750145B2 (en) 2004-11-18 2010-07-06 Kissei Pharmaceutical Co., Ltd. 1-substituted-3-β-D-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same
TWI418556B (zh) * 2006-07-27 2013-12-11 Mitsubishi Tanabe Pharma Corp 吲哚衍生物
UA113086C2 (xx) 2012-05-10 2016-12-12 Піразольні сполуки як інгібітори sglt1
TW201425326A (zh) * 2012-10-05 2014-07-01 Lilly Co Eli 新穎脲化合物

Also Published As

Publication number Publication date
JP2016535032A (ja) 2016-11-10
HRP20171514T1 (hr) 2017-11-17
CY1119540T1 (el) 2018-03-07
PL3063162T3 (pl) 2018-01-31
PE20160663A1 (es) 2016-07-09
HUE034689T2 (hu) 2018-02-28
EA201690593A1 (ru) 2016-08-31
MA38991B1 (fr) 2018-09-28
ES2646125T3 (es) 2017-12-12
AP2016009137A0 (en) 2016-04-30
RS56417B1 (sr) 2018-01-31
CA2924516A1 (en) 2015-05-07
CL2016000988A1 (es) 2016-11-11
JP6147429B2 (ja) 2017-06-14
NO3099623T3 (es) 2018-04-21
BR112016008704B1 (pt) 2022-11-29
AU2014342612B2 (en) 2016-09-29
EP3063162B1 (en) 2017-08-16
DOP2016000062A (es) 2016-03-31
KR101838826B1 (ko) 2018-03-14
PH12016500809B1 (en) 2016-06-13
BR112016008704A8 (pt) 2020-03-17
AR098134A1 (es) 2016-05-04
PT3063162T (pt) 2017-11-14
AU2014342612A1 (en) 2016-03-31
EP3063162A1 (en) 2016-09-07
IL244896A0 (en) 2016-05-31
UA117137C2 (uk) 2018-06-25
KR20160060138A (ko) 2016-05-27
ME02839B (me) 2018-01-20
LT3063162T (lt) 2017-10-25
MA38991A1 (fr) 2017-11-30
NZ717880A (en) 2017-12-22
WO2015065956A1 (en) 2015-05-07
US9145437B2 (en) 2015-09-29
TN2016000125A1 (en) 2017-10-06
HK1222661A1 (zh) 2017-07-07
SI3063162T1 (sl) 2017-10-30
EA029516B1 (ru) 2018-04-30
TW201609784A (zh) 2016-03-16
US20150126469A1 (en) 2015-05-07
CN105636972B (zh) 2018-05-22
DK3063162T3 (en) 2017-10-02
MX2016005428A (es) 2016-08-11
TWI657093B (zh) 2019-04-21
CA2924516C (en) 2019-09-10
CN105636972A (zh) 2016-06-01
IL244896B (en) 2019-02-28
SG11201602950UA (en) 2016-05-30
JO3298B1 (ar) 2018-09-16
PH12016500809A1 (en) 2016-06-13

Similar Documents

Publication Publication Date Title
DOP2016000085A (es) Amino-heteroaril-benzamidas como inhibidores de cinasa
CR20150418A (es) Compuestos de tetrahidropirrolotiazina
CR20140166A (es) Compuestos de (hetero)arilciclopropilamina como inhibidores de lsd1
CU24397B1 (es) Derivados de piperidinil-indol como inhibidores del factor de complemento b
BR112016006366A2 (pt) uso de picolinamidas macrocíclicas como fungicidas
CR20150447A (es) Nuevos derivados de pirazol
CR20150470A (es) Derivados de triazolona de piridinilo y piridinilo fusionado
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
EA201500801A1 (ru) Бензохинолоновые ингибиторы vmat2
AR098274A1 (es) Inhibidor de grelina o-acil transferasa
EA201690894A1 (ru) Феноксиэтилы
EA201591567A1 (ru) Новые производные пиридина
PH12015502471A1 (en) Purine derivatives as cb2 receptor agonists
BR112015029348A2 (pt) inibidores da bace
AR095097A1 (es) Compuestos de fenoxietoxi
DOP2015000176A (es) Compuestos de azetidiniloxifenilpirrolidina
AR091888A1 (es) Compuestos de urea y su uso como inhibidores de enzimas
CL2019000487A1 (es) Derivado de triazolopirazinona útil como un inhibidor de pde1 humana.
MX2015016766A (es) Nuevos derivados de tetrazolona.
CR20160146A (es) Derivados de urea indol sustituido con glucopiranosil y su uso como inhibidores sglt
PH12015502462A1 (en) Imidazo-triazine derivatives as pde10 inhibitors
AR092627A1 (es) Derivados glucopiranosidos de urea
UY34986A (es) Derivados de diazepinona
AR108363A1 (es) Compuestos de tetrahidrofurooxazina y su uso como inhibidores de bace1 selectivos
CR20160175A (es) Amino-heteroaril-benzamidas como inhibidores de cinasa